We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Tacere Enters Collaboration and License Agreement with Pfizer to Develop and Commercialize RNAi Hepatitis C Drug

News   Jan 10, 2008

 
Tacere Enters Collaboration and License Agreement with Pfizer to Develop and Commercialize RNAi Hepatitis C Drug
 
 
 

RELATED ARTICLES

Tropical Flower Could Help Treat Pancreatic Cancer

News

Researchers have created three new molecules similar to Grandifloracin, a chemical found in the tropical plant Uvaria grandiflora, which grows in Malaysia, Indonesia, Thailand and the Philippines.

READ MORE

Ancient Worm Reveals a Way To Destroy Toxic Cells in Huntington's Disease

News

A highly conserved mechanism in worms and humans has been identified, that controls the removal of toxic protein aggregates – hallmarks of neurodegenerative diseases. Insights from their study may provide a novel therapeutic approach for Huntington's and Parkinson's disease.

READ MORE

The Power of Collaboration: Tackling Pharmaceutical Challenges

News

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE